Ownership history in Caption Management, LLC · 21 quarters on record
This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in DENALI THERAPEUTICS INC (DNLI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 91,200 | +61,200 | +204.0% | 0.01% | $1.3M | $14.52 |
| 2025 Q3 | ADDED | 30,000 | +22,634 | +307.3% | 0.00% | $436K | $14.52 |
| 2025 Q3 | REDUCED | 7,366 | -22,634 | -75.4% | 0.00% | $107K | $14.52 |
| 2024 Q4 | UNCHANGED | 30,000 | — | 0% | 0.01% | $611K | $20.38 |
| 2024 Q4 | ADDED | 30,000 | +10,100 | +50.8% | 0.01% | $611K | $20.38 |
| 2024 Q4 | REDUCED | 19,900 | -10,100 | -33.7% | 0.00% | $406K | $20.38 |
| 2024 Q2 | UNCHANGED | 30,000 | — | 0% | 0.01% | $697K | $23.22 |
| 2024 Q2 | UNCHANGED | 30,000 | — | 0% | 0.01% | $697K | $23.22 |
| 2023 Q4 | UNCHANGED | 30,000 | — | 0% | 0.01% | $644K | $21.46 |
| 2023 Q4 | ADDED | 30,000 | +27,000 | +900.0% | 0.01% | $644K | $21.46 |
As of 2025 Q4 — sorted by position size